Gene Editing
Opinion: Redefining sustainability in health care: putting patients before profits
Sustainability appears to be a priority for most companies today, with teams of staff at major corporations dedicated to it and to providing strong messaging on its importance. But in terms of the real, practical implications for consumers, these efforts frequently fall short. In the pharmaceutical industry, sustainability is often a poorly defined buzzword, and the goal seems to be maintaining profit-making over the short term rather than sustaining health for populations in the long term.
Although investors now judge more and more businesses on their environmental, social and governance (ESG) performance, a 2021 analysis showed that only 0.2% of companies around the world were strongly aligned with the United Nations Sustainable Development Goals.
